Logistics & IT
The “Logistics & IT” segment comprises the two business areas “Wholesale” and “Logistics & IT Services”. They operate and develop the logistics and IT platforms of the Galenica Group and offer services to all healthcare providers such as pharmacies, drugstores, physicians, hospitals and care homes.

The focus is on optimising and further developing the range of logistics and services as well as innovative solutions to promote digitalisation in the healthcare market.
“Logistics & IT” segment key figures
The “Logistics & IT” segment performed well in 2025 and generated net sales of CHF 3,332.6 million (+4.8%). Of this, CHF 3,255.3 million (+4.8%) was attributable to the “Wholesale” sector and CHF 79.6 million (+2.8%) to the “Logistics & IT Services” sector.
The adjusted1) operating result (EBIT) improved by +14.8% year-on-year to CHF 61.7 million and the adjusted1) return on sales (ROS) increased from 1.7% to 1.9%. The improved EBIT performance was due to the one-off special effects of CHF 6.2 million in the year 2025, thanks to significantly lower sanctions than originally expected in two competition proceedings.
Excluding the one-off special factors in the previous year, EBIT improved by 3.2%, while the adjusted1) return on sales (ROS) fell slightly by 0.1 percentage points to 1.6% due to the inefficiencies associated with the ERP transition at Galexis.
Investments totalled CHF 18.1 million (previous year: CHF 25.8 million). These were primarily used for the gradual introduction of the new ERP software at Galexis and for the development of the digital infrastructure.
1) See definition in chapter "Alternative performance measures".

Wholesale
In the “Wholesale” sector, sales grew by 4.8% to CHF 3,255.3 million. Both the physicians segment with growth of 3.9% as well as the pharmacy segment with growth of 5.3% performed in line with the market.
In the same period, the overall pharmaceutical market grew by 5.0%2, the physicians segment grew by 3.9%2 and the inpatient pharmacy segment grew by 5.3%2.
2) IQVIA, Pharmaceutical Market Switzerland, 2025
Increased market share in the medical and wholesale markets
Galexis can look back on a successful financial year. The pharmacies, drugstores, hospitals and physicians segments showed pleasing growth. Attendance at important pharmaceutical conferences, customer events and forums ensured market proximity and intensive dialogue with customers. The acquisition of Labor Team by Galenica also opens new growth areas in the medical market for Galexis and Pharmapool. Galexis already expanded its range with laboratory instruments and other accessories for medical practice in 2024, in order to offer integrated laboratory services for doctors in the future. In the reporting year, Galexis and Labor Team began to develop synergies in terms of services, processes and market penetration.
ERP modernisation in Lausanne-Ecublens successfully consolidated
Galexis reached an important milestone in 2025: the conversion of the ERP system at the Lausanne-Ecublens distribution centre was implemented, making Galexis a pioneer in pharmaceutical wholesale in French-speaking Switzerland. With the integrated warehouse management system SAP EWM at the heart of logistics and new, system-guided order picking solutions, the degree of automation increased to over 70%. In the second half of the year, the focus was on stabilising processes, expanding the range and fully supplying customers in French-speaking Switzerland from Lausanne-Ecublens. By the end of the year, Galexis achieved a daily delivery capability of around 99% on more than 17,000 items. The aim is to increase the volume processed in Lausanne-Ecublens by around 30% in 2026 and increase productivity by additional 3%. For customers, this means faster and more reliable availability.

Introduction of SAP in logistics as a comprehensive transformation project
The switch to SAP in Lausanne-Ecublens was not only an IT project, but also a major transformation project that took place during ongoing operations and placed high demands on employees. In view of growing complexity in logistics, automation and digitalisation are indispensable: the increase in generics and biosimilars is raising the variety of items and the demands placed on the cold chain. Since 2020, the number of preparations in the cold zones has increased by 35%.
The introduction of SAP meant much more than a change of system: processes had to be re-learned, collaboration had to be organised differently, and an open attitude to change had to be cultivated. These changes promote efficiency, transparency and a future-facing way of working throughout the company.
The experience gained from Lausanne-Ecublens is being incorporated into preparations for the SAP roll-out at the Niederbipp site and into further organisational development. With the complete renewal of the ERP system landscape, which will be completed in 2026, Galexis is laying the foundations for further growth and a high level of security of supply in the long term.

Logistics & IT Services
Net sales in the “Logistics & IT Services” area grew by 2.8% to CHF 79.6 million.
Alloga and Swiss Post enter into a strategic partnership
2025 was another successful year for Alloga. After completion of the SAP project in 2024, the company transformed its organisation using lean methods and created forward-looking, role-based structures. The consistent implementation of the efficiency programmes has once again significantly increased performance and established it in the long term. At the same time, Alloga made investments specifically in the development of its managers and employees. A strategic partnership with Swiss Post also enabled Alloga to expand its storage capacities and thus strengthen Switzerland’s security of supply with pharmaceutical products. Swiss Post is providing additional pallet spaces in the room temperature zone (15°–25°C) in the highly automated, Swissmedic-certified logistics centre in Villmergen.

Compendium and Documedis: connected for better care
The digitalisation of healthcare is the core area of expertise of HCI Solutions. The company supports healthcare professionals with high-quality data and e-health solutions that improve treatment quality and patient safety. Once a printed standard work, compendium.ch is now an established digital reference with medical information for healthcare professionals and patients. A medical editorial team ensures the quality and relevance of the content.
Compendium.ch uses the Documedis® platform, also developed by HCI Solutions, as the basis for verified data and services. Documedis® is already used by more than 300 systems and applications in the Swiss healthcare system. It was presented to the eHealth community at HCI Connect in mid-November 2025 and met with great interest. HCI Solutions is thus strengthening its positioning as a digital centre of excellence within the Galenica Group. Developers can register at Documedis® and gain access to interfaces and services in the Galenica network, such as regarding pharmacy opening hours or ordering processes at Galexis.
The platform thus makes it easier to integrate products and services and accelerates digitalisation in healthcare. Documedis® supports health professionals with clinical decision support checks (Documedis CDS.CE), among other things. These make it possible to check medications for risks, duplicate prescriptions or possible allergies. Last year, the checks were used over 553 million times – a valuable contribution to improving patient safety.

HCI as an expert partner for the Electronic Prescription Switzerland initiative
In autumn 2025, as part of the revision of the Therapeutic Products Act, the Federal Council announced that medical prescriptions will have to be issued and redeemed electronically in future. Galenica is driving forward electronic prescriptions (e-prescriptions) together with HCI Solutions. HCI Solutions is an expert partner for digital solutions such as the “Electronic Prescription Switzerland” initiative, which was launched jointly by the industry associations pharmaSuisse and FMH. At a roundtable initiated by Galenica in late autumn, these and other stakeholders discussed specific steps to promote e-prescriptions. There was consensus that its establishment is only possible through coordinated collaboration and consistent integration into the primary systems of physicians, hospitals and pharmacies. Customers can already redeem their e-prescriptions in the pharmacies in the Galenica network.
Responsible use of AI
By creating the Data & AI Governance Board, Galenica clearly established AI governance in 2025, taking an important step towards the implementation of the Galenica Data & AI Strategy. As a key component of the Galenica strategy, it creates transparency, gives direction and drives innovation for employees and managers, making a direct contribution to the achievement of corporate goals.